These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 7482321)
1. [Antihyperlipidemic actions in the treatment of nephropathies]. Neverov NI; Tareeva IE; Miroshnichenko NG; Stavrovskaia EV Ter Arkh; 1995; 67(8):15-7. PubMed ID: 7482321 [TBL] [Abstract][Full Text] [Related]
2. [Means for the inhibition of the nonimmune progression of nephritis]. Tareeva IE; Kutyrina IM; Neverov NI Klin Med (Mosk); 1995; 73(3):80-3. PubMed ID: 8577123 [TBL] [Abstract][Full Text] [Related]
3. Clinical investigation on the hypolipidemic effect of simvastatin versus probucol in hemodialysis patients. Fiorini F; Patrone E; Castelluccio A Clin Ter; 1994 Sep; 145(9):213-7. PubMed ID: 7813167 [TBL] [Abstract][Full Text] [Related]
4. Does lipid-lowering therapy slow progression of chronic kidney disease? Wheeler DC Am J Kidney Dis; 2004 Nov; 44(5):917-20. PubMed ID: 15492960 [No Abstract] [Full Text] [Related]
5. Relative effectiveness of niacin and lovastatin for treatment of dyslipidemias in a health maintenance organization. O'Connor PJ; Rush WA; Trence DL J Fam Pract; 1997 May; 44(5):462-7. PubMed ID: 9152263 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of lipid-lowering medications in patients treated with clozapine: a naturalistic study. Landry P; Dimitri E; Tessier S; Légaré N J Clin Psychopharmacol; 2008 Jun; 28(3):348-9. PubMed ID: 18480696 [No Abstract] [Full Text] [Related]
11. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia]. Martínez-Castelao A Med Clin (Barc); 1995 Nov; 105(18):719. PubMed ID: 8538262 [No Abstract] [Full Text] [Related]
12. Bezafibrate and lovastatin decrease the oxidizability of low-density lipoproteins in heart transplant recipients with hyperlidemia. Zambrana JL; López-Miranda J; Blanco A; Arizón JM; Jansen S; Paniagua JA; Jimenéz-Perepérez JA; Concha M; Pérez-Jiménez F J Heart Lung Transplant; 1998 Dec; 17(12):1213-9. PubMed ID: 9883763 [TBL] [Abstract][Full Text] [Related]
13. [Hypolipidemic action of simfibrate in diabetic subjects]. Gragnoli G; Tanganelli I; Signorini AM; Kristodhullu A Clin Ter; 1981 Feb; 96(4):397-408. PubMed ID: 7214862 [No Abstract] [Full Text] [Related]
14. Management of patients with dyslipidaemia. Mann J; Chisholm A; Crooke M; Jackson R; Neutze J; North D; Swinburn B; White H; Wilcox J N Z Med J; 1995 Oct; 108(1010):444. PubMed ID: 7478355 [No Abstract] [Full Text] [Related]
15. [The characteristics of the hypolipidemic effect of Mevacor with its permanent multiyear use]. Lipovetskiĭ BM Ter Arkh; 1996; 68(12):72-5. PubMed ID: 9054048 [TBL] [Abstract][Full Text] [Related]
16. Three new drugs for hyperlipidemia. Med Lett Drugs Ther; 2003 Mar; 45(1151):17-9. PubMed ID: 12612501 [No Abstract] [Full Text] [Related]
17. [A trial of long-term lovastatin treatment in patients with a heterozygous form of hereditary hypercholesterolemia]. Alidzhanova KhG; Eliseev AO; Tvorogova MG; Buriachkovskaia LI; Chuĭkin NA; Tripol'skaia LV; Kukharchuk VV Ter Arkh; 1997; 69(8):13-7. PubMed ID: 9381383 [TBL] [Abstract][Full Text] [Related]
18. [Prevention and therapy of vascular damage and endothelial dysfunction with hypocholesteremic agents]. De Caterina R; Lenzi S G Ital Cardiol; 1998 Feb; 28(2):168-77. PubMed ID: 9534058 [TBL] [Abstract][Full Text] [Related]
19. Treatment of and screening for hyperlipidemia. Barth JD N Engl J Med; 1993 Oct; 329(15):1125; author reply 1127. PubMed ID: 8371741 [No Abstract] [Full Text] [Related]
20. [Effect of combined treatment with lovastatin and colestipol on serum lipids and lipoproteins]. Kłosiewicz-Latoszek L; Nowicka G; Szostak WB Wiad Lek; 1993 Aug; 46(15-16):581-5. PubMed ID: 7975581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]